secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lantern Pharma Inc. (LTRN)
CIK:        0001763950
Form:       8-K
Filed at:   2025-01-10T23:59:59+00:00
Accession:  0001493152-25-001685
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Lantern Pharma amends CSO Bhatia's agreement: term to Jan 2026, reduced hours, $189,600 salary
--------------------------------------------------------------------------------

- Kishor G. Bhatia, CSO, employment term extended to January 15, 2026.
- Minimum weekly hours reduced to 24 for scientific, clinical, and therapeutic development.
- Annual base salary proportionately adjusted to $189,600 effective first pay period January 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1763950/000149315225001685/0001493152-25-001685-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1763950/000149315225001685/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-001685

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer